Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin E Stryjewski

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Chest|December 7, 2021
A 31-Year-Old Man With Seizures, Brain Lesion, and Lung NodulesLuis Patricio Maskin, Matias H Garcia Hernandez, Martin E Stryjewski, et al.
Chest|May 8, 2022
ResponseLuis Patricio Maskin, Matias H Garcia Hernandez, Martin E Stryjewski, et al.
Scandinavian Journal of Infectious Diseases|August 18, 2009
Nephrotoxicity associated with the use of intravenous colistinCecilia Santamaría, Analia Mykietiuk, Elena Temporiti, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2015
Telavancin for Acute Bacterial Skin and Skin Structure Infections, a Post Hoc Analysis of the Phase 3 ATLAS Trials in Light of the 2013 FDA GuidanceRichard Pushkin, Steven L Barriere, Whedy Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2014
Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureusG Ralph Corey, Ethan Rubinstein, Martin E Stryjewski, et al.
BMC Infectious Diseases|April 9, 2014
Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studiesSteven L Barriere, Martin E Stryjewski, G Ralph Corey, et al.
Infectious Diseases and Therapy|October 9, 2016
Assessment of Minimum Inhibitory Concentrations of Telavancin by Revised Broth Microdilution Method in Phase 3 Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Clinical IsolatesJennifer I Smart, Gordon Ralph Corey, Martin E Stryjewski, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 2017
Assessment of telavancin minimal inhibitory concentrations by revised broth microdilution method in phase 3 complicated skin and skin-structure infection clinical trial isolatesJennifer I Smart, G Ralph Corey, Martin E Stryjewski, et al.
Journal of Clinical Microbiology|May 8, 2003
Sepsis, multiple organ failure, and death due to Pandoraea pnomenusa infection after lung transplantationMartin E Stryjewski, John J LiPuma, Robert H Messier, et al.
International Journal of Antimicrobial Agents|December 3, 2014
Inhaled colistimethate sodium in ventilator-associated tracheobronchitis due to multidrug-resistant Gram-negative bacteriaLuis Patricio Maskin, Mariano Setten, Pablo O Rodríguez, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Chest|December 7, 2021
A 31-Year-Old Man With Seizures, Brain Lesion, and Lung NodulesLuis Patricio Maskin, Matias H Garcia Hernandez, Martin E Stryjewski, et al.
Chest|May 8, 2022
ResponseLuis Patricio Maskin, Matias H Garcia Hernandez, Martin E Stryjewski, et al.
Scandinavian Journal of Infectious Diseases|August 18, 2009
Nephrotoxicity associated with the use of intravenous colistinCecilia Santamaría, Analia Mykietiuk, Elena Temporiti, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2015
Telavancin for Acute Bacterial Skin and Skin Structure Infections, a Post Hoc Analysis of the Phase 3 ATLAS Trials in Light of the 2013 FDA GuidanceRichard Pushkin, Steven L Barriere, Whedy Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2014
Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureusG Ralph Corey, Ethan Rubinstein, Martin E Stryjewski, et al.
BMC Infectious Diseases|April 9, 2014
Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studiesSteven L Barriere, Martin E Stryjewski, G Ralph Corey, et al.
Infectious Diseases and Therapy|October 9, 2016
Assessment of Minimum Inhibitory Concentrations of Telavancin by Revised Broth Microdilution Method in Phase 3 Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Clinical IsolatesJennifer I Smart, Gordon Ralph Corey, Martin E Stryjewski, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 2017
Assessment of telavancin minimal inhibitory concentrations by revised broth microdilution method in phase 3 complicated skin and skin-structure infection clinical trial isolatesJennifer I Smart, G Ralph Corey, Martin E Stryjewski, et al.
Journal of Clinical Microbiology|May 8, 2003
Sepsis, multiple organ failure, and death due to Pandoraea pnomenusa infection after lung transplantationMartin E Stryjewski, John J LiPuma, Robert H Messier, et al.
International Journal of Antimicrobial Agents|December 3, 2014
Inhaled colistimethate sodium in ventilator-associated tracheobronchitis due to multidrug-resistant Gram-negative bacteriaLuis Patricio Maskin, Mariano Setten, Pablo O Rodríguez, et al.
Pageof 9